Good evening :)
Place Order
Add to Watchlist

Bilcare Ltd

BI

Bilcare Ltd

BI
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹138 cr, stock is ranked 2,813
High RiskStock is 3.54x as volatile as Nifty
70.6320.00% (+11.77)
70.6320.00% (+11.77)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹138 cr, stock is ranked 2,813
High RiskStock is 3.54x as volatile as Nifty

How to use scorecard? Learn more

Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹138 cr, stock is ranked 2,813
High RiskStock is 3.54x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-3.450.21—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.236.640.52%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bilcare Limited offers pharmaceutical packaging solutions that are used in pharmaceutical products. It’s other packaging films solutions cater to various industries like ID card industry, specialty films applications and food packaging.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -24.11%, vs industry avg of 4.51%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 24.93% to 4.37%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue2,914.812,741.793,079.163,057.252,082.32672.50891.801,301.65769.70791.12
Raw Materialssubtract1,426.451,380.801,577.381,631.68797.66416.44607.37730.32520.36745.24
Power & Fuel Costsubtract122.15118.24118.81119.8473.6429.8034.3542.8439.64
Employee Costsubtract510.49524.42558.54616.93370.7855.3059.2771.2671.87
Selling & Administrative Expensessubtract268.45142.51136.43163.51104.3520.4628.0131.8725.46
Operating & Other expensessubtract467.37278.58229.97296.61436.5954.3758.84131.4657.34
Depreciation/Amortizationsubtract163.60176.95416.19378.36238.8045.5139.2537.8144.9546.53
Interest & Other Itemssubtract150.76176.35249.06282.84174.1675.5968.9360.0081.7987.66
Taxes & Other Itemssubtract-109.6128.47-6.0722.58-10.11-3.888.37181.04-38.47-48.15
EPS-36.04-35.90-85.43-193.29-43.98-8.96-5.356.39-14.12-17.06
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2015

Annual report

PDF
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareLabs & Life Sciences Services

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Bilcare Ltd-4.170.21—
Divi's Laboratories Ltd96.0311.320.52%
Syngene International Ltd66.717.990.15%
Aarti Pharmalabs Ltd24.473.020.51%

Price Comparison

Compare BI with any stock or ETF
Compare BI with any stock or ETF
BI
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding30.01%0.00%0.00%0.04%69.94%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.04%0.04%0.04%0.04%0.04%0.04%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

BI has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 20, 2012

Final
Final | Div/Share: ₹2.00

Dividend/Share

₹2.00

Ex DateEx Date

Sep 20, 2012

Cash Dividend

Ex DateEx DateSep 20, 2011

Final
Final | Div/Share: ₹3.00

Dividend/Share

₹3.00

Ex DateEx Date

Sep 20, 2011

News & Opinions
Earnings
Bilcare reports consolidated net loss of Rs 16.03 crore in the September 2024 quarter

Net Loss of Bilcare reported to Rs 16.03 crore in the quarter ended September 2024 as against net loss of Rs 7.59 crore during the previous quarter ended September 2023. Sales rose 6.22% to Rs 201.74 crore in the quarter ended September 2024 as against Rs 189.92 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales201.74189.92 6 OPM %3.798.79 - PBDT-12.127.15 PL PBT-23.16-3.33 -595 NP-16.03-7.59 -111 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Bilcare to conduct board meeting

Bilcare will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Bilcare AGM scheduled

Bilcare announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Bilcare standalone net profit declines 89.57% in the June 2024 quarter

Net profit of Bilcare declined 89.57% to Rs 1.40 crore in the quarter ended June 2024 as against Rs 13.42 crore during the previous quarter ended June 2023. Sales rose 33.06% to Rs 4.87 crore in the quarter ended June 2024 as against Rs 3.66 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales4.873.66 33 OPM %-17.45-39.62 - PBDT2.36-0.99 LP PBT1.63-1.43 LP NP1.4013.42 -90 Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Bilcare reports consolidated net loss of Rs 6.39 crore in the June 2024 quarter

Net Loss of Bilcare reported to Rs 6.39 crore in the quarter ended June 2024 as against net loss of Rs 7.91 crore during the previous quarter ended June 2023. Sales rose 6.52% to Rs 194.14 crore in the quarter ended June 2024 as against Rs 182.25 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales194.14182.25 7 OPM %9.767.39 - PBDT1.83-1.95 LP PBT-9.69-12.45 22 NP-6.39-7.91 19 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Bilcare to table results

Bilcare will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live